Propofol is a prescription, injectable anaesthetic drug used to decrease the activity of the brain and central nervous system. It is administered intravenously and is widely utilized in general anaesthesia to perform minimally invasive surgeries. Propofol is used in sedation procedures for mechanically ventilated adults, in procedural sedation, and for status epilepticus when other drugs have not produced desired results.
|Value (USD Million)
The market for propofol is highly concentrated. AstraZeneca sells Diprivan, the branded propofol product. Baxter markets the only generic propofol product, which is manufactured by GensiaSicor. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Propofol market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Astrazeneca plc (United Kingdom), Baxter International Inc. (United States), Hikma Pharmaceuticals PLC (United Kingdom), Mylan N.V. (United States), B.Braun Melsungen (Germany), Eisai Co., Ltd. (Japan), Bachem (Switzerland), Fresenius Se & Co. Kgaa (Germany), Hospira, Inc. (United Kingdom) and Par Pharmaceutical Companies, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Fresenius Kabi (Germany), Xi'an Libang (China), Sichuan Guorui (China), Guangdong Jiabo (China), Jiangsu Nhwa (China) and Piramal Critical Care Limited (United Kingdom).
AMA Research has segmented the market of Global Propofol market by Type (Local Anaesthesia and General Anesthesia), Application (Medical Uses and Other Uses) and Region.
On the basis of geography, the market of Propofol has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Route of Administration, the sub-segment i.e. Intravenous will boost the Propofol market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Research And Development Activities Initiated By The Leading Players For New Products Development
Market Growth Drivers:
Increasing In Number Of Cataract Removal Surgeries and Rapidly Increase In Number Of Orthodontic And Dental Surgical Procedures
Side Effects Such As Reduced Heart Rate And Low Blood Pressure
High Cost involved in Propofol
Increase In The Number Of General Surgical Procedures
In Jan 2019, Dr. Reddy's Laboratories announces the launch of Propofol Injectable Emulsion, USP in the U.S. Market.
"FDA has issued alert to inform healthcare professionals about several clusters of patients who have experienced chills, fever, and body aches shortly after receiving propofol for sedation or general anesthesia. FDA has tested multiple units of propofol vials and lots used in patients who have experienced these symptoms and to date, these tests have not identified any vials contaminated with bacteria or endotoxins."
Key Target Audience
Propofol Manufacturers, Propofol Distributors/Traders/Wholesalers, Propofol Subcomponent Manufacturers, Industry Association, Market research and consulting firms, Downstream Vendors, Government regulatory authorities and Others
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.